Black Seed Oil Cholesterol Randomized Trial: What the Evidence Says
Black Seed Oil Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Quick Answer
Black Seed Oil Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 systematic review, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Black Seed Oil Cholesterol Randomized Trial: What the Evidence Says
Quick Answer
Black Seed Oil Cholesterol Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review | systematic review | 1 | 2026-02-27 | 10.1186/s13048-026-02030-z |
| Black Cumin Seed ( Nigella sativa ) Confers Anti‐Adipogenic Effects in 3T3‐L1 Cellular Model and Lipid‐Lowering Properties in Human Subjects | preclinical study | 4 | 2025-09-01 | 10.1002/fsn3.70888 |
What The Sources Report
- PCOS increases the risk of other disorders, including type 2 diabetes, dyslipidemia, high blood pressure, cancers, infertility, and metabolic diseases such as insulin resistance. [Dashti Sareh (2026); evidence level 1]
- Conventional pharmacological interventions, such as hormonal contraceptives, insulin sensitizers, and ovulation-inducing agents are effective in symptom control, but may be associated with side effects, contraindications, or limited patient adherence. [Dashti Sareh (2026); evidence level 1]
- Obesity is a global health concern associated with metabolic disorders such as insulin resistance, dyslipidemia, and cardiovascular diseases (Ginsberg ; Powell-Wiley et al. ). [Ahmed Shamima (2025); evidence level 4]
- These effects are particularly beneficial for individuals with hypercholesterolemia or other cardiovascular risk factors (Hosseinzadeh et al. ; Sahebkar et al. ). [Ahmed Shamima (2025); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For black seed oil cholesterol randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Dashti Sareh (2026). Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. DOI: 10.1186/s13048-026-02030-z. PMCID: PMC13041406. PMID: 41761211. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13041406/
- Ahmed Shamima (2025). Black Cumin Seed ( Nigella sativa ) Confers Anti‐Adipogenic Effects in 3T3‐L1 Cellular Model and Lipid‐Lowering Properties in Human Subjects. DOI: 10.1002/fsn3.70888. PMCID: PMC12401715. PMID: 40905014. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12401715/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed June 1, 2026 by Migaku Evidence Review
